Envoy Medical
COCH
16 hedge funds and large institutions have $24.9M invested in Envoy Medical in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 9 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
23.02% less ownership
Funds ownership: 92.71% → 69.68% (-23%)
24% less funds holding
Funds holding: 21 → 16 (-5)
39% less capital invested
Capital invested by funds: $40.9M → $24.9M (-$16M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$1.41M |
| 2 |
CS
Clear Street
New York
|
+$1.27M |
| 3 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$1.08M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$266K |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$200K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSU
Mizuho Securities USA
New York
|
-$2.44M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$2M |
| 3 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$1.93M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
-$1.52M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$1.44M |
COCH Hedge Fund Activity: Q3 2023 in Review
16 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2023, worth a combined $24.9M — down 39% from $40.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of COCH and 4 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Meteora Capital, adding an estimated $1.41M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $2.44M sold.
- 16 institutional investors held Envoy Medical (COCH) as of Q3 2023, down from 21 in Q2 2023.
- Funds reported $24.9M of Envoy Medical stock for Q3 2023, down 39% quarter-over-quarter.
- 4 funds opened new Envoy Medical positions in Q3 2023 and 9 closed out, a net change of -5 holders.
- The largest Envoy Medical buyer in Q3 2023 was Meteora Capital, an estimated $1.41M added.
- The largest Envoy Medical seller in Q3 2023 was Mizuho Securities USA, an estimated $2.44M sold.
Based on aggregated 13F filings for Q3 2023.